INNOVANCE Anti-Xa (OPPU05) and 2 more
Anti-Factor Xa Activity Test System, Apixaban. 510(k) K240315, from Siemens Healthcare Diagnostics Products GmbH (Marburg, DE). Product code QLU, class 2.
As of Nov 20, 2026, K240315 is an FDA 510(k) held by Siemens Healthcare Diagnostics Products GmbH, substantially equivalent on Oct 10, 2024 after 251 days, with no recalls tied to it in FDA's recall database.
- Review time: 251 days
- Recalls: 0
INNOVANCE Anti-Xa assay in combination with INNOVANCE Heparin Calibrator is an In-vitro diagnostic automated chromogenic assay for the quantitative determination of unfractionated heparin (UFH) and low molecular weight heparin (LMWH) activity in human plasma collected from venous blood samples in 3.2 % sodium citrated tubes in the clinical laboratory.
- HemosIL Liquid Anti-XaDEN190032 · Instrumentation Laboratory CO · Sep 17, 2020
- HemosIL Liquid Anti-XaK213464 · Instrumentation Laboratory CO · Oct 4, 2022
- HemosIL Liquid Anti-XaK223187 · Instrumentation Laboratory CO · Jun 23, 2023
- Acl Top (Acl Top 700, Acl Top 700 Cts, Acl Top 700 Las, Acl Top 500 Cts, Acl Top 300 Cts)K160276 · Instrumentation Laboratory CO · Mar 3, 2016
- Acl Top Family 50 Series: Acl Top 350 Cts; Acl Top 550 Cts; Acl Top 750; Acl Top 750 Cts; Acl Top 750 LasK150877 · Instrumentation Laboratory CO · Dec 13, 2015
- Automated Blood Coagulation Analyzer CS-2500K172286 · Siemens Healthcare Diagnostic Products GmbH · Dec 18, 2017
- HemosIL Liquid Anti-XaK223187 · Instrumentation Laboratory CO · Jun 23, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Feb 2, 2024
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7295
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files